Mankind Pharma leans heavily on India’s low-cost medicines, and tighter rules and pricing limits could make it harder to grow while squeezing what it earns on each sale. At the same time, shifts toward online healthcare and tougher global approval standards may challenge its playbook just as rivals and new product bets try to lift profits.Read more
Mankind Pharma looks set to ride India’s growing demand for healthcare, helped by a fast integration of a recent deal, stronger consumer brands, and a deeper push into treatments for long-term illnesses like diabetes and obesity. But heavy dependence on India, rising costs, and tougher rules could make it harder to protect profits as competition heats up.Read more
Mankind Pharma is leaning into long-term treatments and fast-growing consumer health brands, with more sales moving online and into modern retail—changes that could make its growth steadier over time. The big catch is that it relies heavily on India and faces cost and regulatory pressure, so the path to better profits may not be smooth.Read more
No trending discussion available.
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural and pet food products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Telmikind-Am, Gudcef, Glimestar-M, Candi Force, Nurokind-Gold, Telmikind-H, Telmikind, Nurokind-Lc, Nurokind Plus-Rf, Vomikind, Cefakind, Glizid-M, Monticope, and Gudcef-Cv brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.
